Gerolymatos International S.a. | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Gerolymatos International S.A.
FDA

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

pharmacompass-1-m-2026-04-20

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

Aspen API. More than just an API™

Contact Supplier

pharmacompass-2-m-2026-04-20

Gerolymatos International S.A.

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow

INSPECTIONS & REGISTRATIONS

3 FDA

3 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

3 All

01 3Gerolymatos International SA

filter District Decision Reset all filters

3 All

01 2No Action Indicated

02 1Voluntary Action Indicated

filter Inspection End Date Reset all filters

3 All

01 12019-02-25

02 12015-01-22

03 12012-12-06

filter City Reset all filters

3 All

01 3Acharnes

filter Country/Area Reset all filters

3 All

01 3Greece

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

AACR Annual meeting

Not Confirmed

FDA Audited

USA

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-02-25

Gerolymatos International S.A.

City : Acharnes

State :

Country/Area : Greece

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-02-25

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

AACR Annual meeting

Not Confirmed

FDA Audited

USA

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2015-01-22

Gerolymatos International S.A.

City : Acharnes

State :

Country/Area : Greece

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2015-01-22

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

AACR Annual meeting

Not Confirmed

FDA Audited

USA

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2012-12-06

Gerolymatos International S.A.

City : Acharnes

State :

Country/Area : Greece

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2012-12-06

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.